The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China

被引:4
|
作者
Zhang, Xi-Ru [1 ,2 ]
Li, Zhi-Ju [1 ]
Fu, Qi [1 ]
Wang, Jin-Dong [1 ]
Huang, Qing-Mei [1 ]
Song, Wei-Qi [1 ]
Xu, Xiao-Yu [1 ]
Li, Zhi-Hao [1 ]
Mao, Chen [1 ,2 ]
机构
[1] Southern Med Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Microbiome Med Ctr, Dept Lab Med, Guangzhou, Peoples R China
关键词
Coronavirus disease 2019; Vaccination; Coverage; Willingness; Related factor; COVID-19; VACCINE; OMICRON;
D O I
10.1186/s12889-023-15294-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundCOVID-19, which is caused by SARS-CoV-2, is a major global health threat. The dominant variant of SARS-CoV-2 has changed over time due to continuous evolution. We aimed to evaluate the coverage of SARS-CoV-2 vaccination among employees in China, explore their willingness to receive the SARS-CoV-2 variant vaccine and examine the potential factors influencing vaccination coverage and willingness.MethodsA cross-sectional epidemiological survey was conducted online from January 1, 2022, to January 30, 2022. The information collected in the survey included sociodemographic characteristics, lifestyle habits, vaccination coverage, willingness to be vaccinated against SARS-CoV-2 variants and the reasons for vaccination and willingness. Multivariable logistic regression models were used to assess the associations of potential factors with the rate of vaccination and the willingness to be vaccinated.ResultsAmong 62,395 eligible participants, the coverage of SARS-CoV-2 vaccination was 98.9% for at least one dose and 70.1% for a booster. The great majority of vaccinated individuals (94.4%) voluntarily received the vaccine. A total of 60,694 respondents (97.7%) were willing to be vaccinated against SARS-CoV-2 variants, mainly due to confidence in the effectiveness of vaccines (92.8%). A total of 1431 respondents were unwilling to be vaccinated, mainly because of concerns about the adverse effects of vaccines (77.6%). Longer education duration was associated with a higher rate of SARS-CoV-2 vaccination and willingness to be vaccinated. General or poor health status and having no history of influenza vaccination were associated with a lower rate of SARS-CoV-2 vaccination and willingness to be vaccinated. Additionally, we observed a significant positive association of abuse experience with the willingness to be vaccinated.ConclusionAlthough the rate of SARS-CoV-2 vaccination and the willingness to be vaccinated were relatively high in the study population, there were still some respondents with vaccine hesitancy. Relevant strategies based on significant related factors should be developed and implemented to encourage vaccination.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Racing for a SARS-CoV-2 vaccine
    Tuereci, Oezlem
    Sahin, Ugur
    EMBO MOLECULAR MEDICINE, 2021, 13 (11)
  • [22] Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2
    Dimeglio, Chloe
    Milhes, Marine
    Loubes, Jean-Michel
    Ranger, Noemie
    Mansuy, Jean-Michel
    Tremeaux, Pauline
    Jeanne, Nicolas
    Latour, Justine
    Nicot, Florence
    Donnadieu, Cecile
    Izopet, Jacques
    VIRUSES-BASEL, 2021, 13 (05):
  • [23] Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
    Cucunawangsih, Cucunawangsih
    Wijaya, Ratna Sari
    Lugito, Nata Pratama Hardjo
    Suriapranata, Ivet
    CASE REPORTS IN INFECTIOUS DISEASES, 2021, 2021
  • [24] Increased vaccine sensitivity of an emerging SARS-CoV-2 variant
    Joseph A. Lewnard
    Vennis Hong
    Jeniffer S. Kim
    Sally F. Shaw
    Bruno Lewin
    Harpreet Takhar
    Marc Lipsitch
    Sara Y. Tartof
    Nature Communications, 14
  • [25] New Variant of SARS-CoV-2 Dynamics with Imperfect Vaccine
    Faniran, Taye Samuel
    Ali, Aatif
    Al-Hazmi, Nawal E. E.
    Asamoah, Joshua Kiddy K.
    Nofal, Taher A. A.
    Adewole, Matthew O. O.
    COMPLEXITY, 2022, 2022
  • [26] Increased vaccine sensitivity of an emerging SARS-CoV-2 variant
    Lewnard, Joseph A.
    Hong, Vennis
    Kim, Jeniffer S.
    Shaw, Sally F.
    Lewin, Bruno
    Takhar, Harpreet
    Lipsitch, Marc
    Tartof, Sara Y.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [27] New Variant of SARS-CoV-2 Dynamics with Imperfect Vaccine
    Faniran, Taye Samuel
    Ali, Aatif
    Al-Hazmi, Nawal E. E.
    Asamoah, Joshua Kiddy K.
    Nofal, Taher A. A.
    Adewole, Matthew O. O.
    COMPLEXITY, 2022, 2022
  • [28] Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
    Souza, William M.
    Amorim, Mariene R.
    Sesti-Costa, Renata
    Coimbra, Lais D.
    Brunetti, Natalia S.
    Toledo-Teixeira, Daniel A.
    Souza, Gabriela F. de
    Muraro, Stefanie P.
    Parise, Pierina L.
    Barbosa, Priscilla P.
    Bispo-dos-Santos, Karina
    Mofatto, Luciana S.
    Simeoni, Camila L.
    Claro, Ingra M.
    Duarte, Adriana S. S.
    Coletti, Thais M.
    Zangirolami, Audrey B.
    Costa-Lima, Carolina
    Gomes, Arilson B. S. P.
    Buscaratti, Lucas, I
    Sales, Flavia C.
    Costa, Vitor A.
    Franco, Lucas A. M.
    Candido, Darlan S.
    Pybus, Oliver G.
    de Jesus, Jaqueline G.
    Silva, Camila A. M.
    Ramundo, Mariana S.
    Ferreira, Giulia M.
    Pinho, Mariana C.
    Souza, Leandro M.
    Rocha, Esmenia C.
    Andrade, Pamela S.
    Crispim, Myuki A. E.
    Maktura, Grazielle C.
    Manuli, Erika R.
    Santos, Magnun N. N.
    Camilo, Cecilia C.
    Angerami, Rodrigo N.
    Moretti, Maria L.
    Spilki, Fernando R.
    Arns, Clarice W.
    Addas-Carvalho, Marcelo
    Benites, Bruno D.
    Vinolo, Marco A. R.
    Mori, Marcelo A. S.
    Gaburo, Nelson
    Dye, Christopher
    Marques-Souza, Henrique
    Marques, Rafael E.
    LANCET MICROBE, 2021, 2 (10): : E527 - E535
  • [29] SARS-CoV-2 among employees in the health and care service
    Molvik, Mari
    Danielsen, Anders Skyrud
    Grosland, Mari
    Telle, Kjetil Elias
    Kacelnik, Oliver
    Eriksen-Volle, Hanne-Merete
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2021, 141 (03) : 237 - 242
  • [30] Esophagitis and SARS-CoV-2 vaccine Vacuna contra la esofagitisy el SARS-CoV-2
    Sriwijitalai, Won
    Wiwanitkit, Viroj
    MEDICINA CLINICA, 2023, 160 (03): : 137 - 137